Valeant Pharmaceuticals To Present At UBS Annual Global Life Sciences Conference

MONTREAL, Sept. 11, 2012 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced members of its senior management team will make a presentation at the UBS annual Global Life Sciences Conference on Thursday, September 20, 2012 at 1:30 p.m. ET. The conference will be held at The Grand Hyatt in New York.

A live webcast and audio archive of the presentation will be available on the company's Web site at www.valeant.com. Click on Investor Relations, and then the link to Events and Presentations. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. The webcast can also be accessed through the following URL: http://cc.talkpoint.com/ubsx001/091912a_im/?entity=3_NU4OL6L

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE: VRX/TSX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology and branded generics.  More information about Valeant can be found at www.valeant.com.

Contact:
Laurie Little
Valeant Pharmaceuticals
949-461-6002

(Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)

SOURCE Valeant Pharmaceuticals International, Inc.

RELATED LINKS
http://www.valeant.com